In conclusion, we report that the majority of CNL patients studied here carried oncogenic CSF3R mutations and that the CSF3R T618I mutation appears to be a diagnostic marker with good specificity and sensitivity for CNL. This evidence concerns the gene CSF3R and chronic neutrophilic leukemia.